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The circadian clock coordinates a variety of immune responses
with signals from the external environment to promote survival.
We investigated the potential reciprocal relationship between the
circadian clock and skin inflammation. We treated mice topically
with the Toll-like receptor 7 (TLR7) agonist imiquimod (IMQ) to
activate IFN-sensitive gene (ISG) pathways and induce psoriasiform
inflammation. IMQ transiently altered core clock gene expres-
sion, an effect mirrored in human patient psoriatic lesions. In
mouse skin 1 d after IMQ treatment, ISGs, including the key ISG
transcription factor IFN regulatory factor 7 (Irf7),were more highly
induced after treatment during the day than the night. Nuclear
localization of phosphorylated-IRF7 was most prominently time-
of-day dependent in epidermal leukocytes, suggesting that these
cell types play an important role in the diurnal ISG response to
IMQ. Mice lacking Bmal1 systemically had exacerbated and ar-
rhythmic ISG/Irf7 expression after IMQ. Furthermore, daytime-
restricted feeding, which affects the phase of the skin circadian
clock, reverses the diurnal rhythm of IMQ-induced ISG expression
in the skin. These results suggest a role for the circadian clock,
driven by BMAL1, as a negative regulator of the ISG response,
and highlight the finding that feeding time can modulate the skin
immune response. Since the IFN response is essential for the anti-
viral and antitumor effects of TLR activation, these findings are
consistent with the time-of-day–dependent variability in the abil-
ity to fight microbial pathogens and tumor initiation and offer
support for the use of chronotherapy for their treatment.
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The skin contains a circadian clock that is under the influenceof the suprachiasmatic nucleus (1, 2) and, surprisingly, feeding
time (3). Coordination of intermediary metabolism with the cell
cycle in epidermal stem cells (4, 5) is one of the key roles of the
skin clock, and there is also strong evidence for clock regulation of
skin resident and migratory immune cells (1, 6). Circadian regu-
lation of mast cells, for example, plays a role in the diurnal vari-
ation of allergic symptoms in the skin (7), and mice mutated for
core circadian clock gene CLOCK have severe skin allergic re-
actions (8). Antigen-presenting dendritic cells (DCs) are recruited
to the skin in a diurnal fashion; loss of circadian control dampens
trafficking of these cells to the skin during delayed-type hyper-
sensitivity reactions (9). The circadian clock also attenuates
imiquimod (IMQ)-induced skin inflammation (10). The circadian
clock, then, influences skin immune cells and modulates the skin’s
inflammatory response, but the reciprocal interactions between
the skin clock and the immune system are not fully understood,
and it is unknown if altered feeding times, which shifts the phase
of the skin clock, affect the skin immune response.
As the first line of defense against pathogens, the skin is para-
mount in preventing and responding to infections. While the in-
fluence of the circadian clock on skin viral infections is incompletely
understood, recent evidence suggests that the circadian clock may
regulate the defense against viral infections in other organs. Mice
intranasally infected with herpes or influenza A viruses during the
daytime have greater infection rates and mortality than mice in-
fected at night. This diurnal effect may be mediated by the cir-
cadian clock as deletion of the core clock gene Bmal1 exacerbates
viral infections (11). Furthermore, disruption of circadian function
by jet lag or Bmal1 deletion leads to increased acute viral bron-
chiolitis after Sendai virus and influenza A viral infections (12).
The mechanism by which the circadian clock and BMAL1 con-
tribute to host defense response against viruses is currently un-
clear. The complex relationship between the circadian clock and
the skin immune system is important not only for defense against
viral infections, but also for tumorigenesis and antitumor actions,
which rely on activation of antiviral pathways, including type I
interferons (IFNs) (13).
IFN mediates greater antiviral effects during the night com-
pared to the day (14), and circadian and feeding time regulation
of IFN in the skin has not been previously described. We used
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the therapeutic drug and single-stranded RNA virus mimic IMQ
as a model system to investigate the circadian clock mechanisms
that may alter the skin’s immune response against tumors or viral
infections. IMQ was originally developed as a topical treatment
for human papilloma virus-associated anogenital warts, and it
has since been approved for the treatment of nonviral tumors
such as actinic keratosis and superficial basal cell carcinomas. IMQ
causes immune activation through induction of antiviral proteins,
proinflammatory cytokines, and chemokines (15).
When IMQ is applied repetitively to mouse skin, it induces
robust inflammation affected by sensory neurons containing
TRPV1 and NaV1.8 ion channels (16). This causes epidermal
hyperproliferation, parakaratosis (nuclei retained in the stratum
corneum), acanthosis (thickening of the epidermis), and Munro’s
microabscesses—features that are similar to human psoriasis (15,
17). In humans, there is a higher incidence of psoriatic lesions in
night-shift workers with misaligned circadian clocks (18). Con-
sistently, the response to IMQ in mice has diurnal features and is
affected by clock gene deletions (10).
IMQ activates TLR7 and TLR8 (in humans) receptors located
on endosomes within a variety of different cell types, including
macrophages (19), keratinocytes (KCs) (20), mast cells (21),
monocytes (22), classic dendritic cells (23), and plasmacytoid den-
dritic cells (24). Upon IMQ binding, TLR7 dimerizes and recruits
the adaptor molecule MyD88, leading to a signaling cascade in-
volving PI3K (13), IRAK1-, IKKα-, and/or LMP1-mediated
phosphorylation, and nuclear translocation of IRF7. Once in the
nucleus, IRF7 binds to IFN-responsive elements (IREs) within
promoters of type I IFN-encoding genes and other IFN-sensitive
genes (ISGs), including Irf7. IRF7, then, is the key transcription
factor induced by this pathway, acting in a feed-forward manner by
facilitating the production of ISGs and type I IFNs through the
MyD88 pathway. This feed-forward loop induces robust expres-
sion of ISGs which activate the immune system to kill cancer cells,
bacteria, and viruses.
The goal of our study was to investigate the reciprocal rela-
tionship between the circadian clock and TLR7-induced in-
flammatory responses in skin. Inflammatory parameters, including
spleen weight, epidermal thickness, and epidermal cell proliferation,
were diurnal under homeostasis and/or after one dose of
topical 1% IMQ, but became arrhythmic and elevated with five
consecutive daily doses of 1% IMQ. Mice lacking Bmal1 system-
ically had greater epidermal thickness at 5 d of IMQ compared to
wild type (Wt). Certain circadian clock genes are also perturbed in
human patient psoriatic skin samples. We show that IMQ alters
core clock gene expression in mouse skin in an acute manner that
recovers after 1 d. Likewise, the early IMQ-induced ISG response
is diurnal in mouse skin, but this diurnal response is lost after
repeated daily IMQ treatments, presumably because of IMQ’s
effect on the clock (25). Consistent with this idea, the ISG re-
sponse is enhanced and occurs without diurnal variation in Bmal1-
deleted mice. Through cell sorting and single-cell RNA sequenc-
ing (RNA-seq) we determined that IMQ up-regulates Irf7 mRNA
more potently in epidermal immune cells (Langerhans cells
[LCs], T cells, and monocytes) than in keratinocytes (26). In-
triguingly, shifting the phase of the core circadian clock through
daytime-restricted feeding alters the rhythm of IMQ-induced ISG
induction. Together, these studies indicate that BMAL1 is a
negative regulator of ISG gene expression in skin immune cells
and that the skin’s antiviral and antitumor response can be mod-
ulated by feeding time.
Results
Repeated Skin Applications of IMQ Dampen Diurnal Rhythms of
Inflammation. We first tested whether there are time-of-day–
dependent inflammatory effects of topically applied IMQ by
treating mice with daily 1% IMQ at early morning (ZT01), af-
ternoon (ZT07), early evening (ZT13), or late night (ZT19) for 1
or 5 d and harvesting skin 24 h after IMQ applications (Fig. 1A).
The circadian clock-dependent diurnal variation in interfollicular
epidermal (IFE) stem cell DNA replication, where most cells are
in S phase late at night (4), is lost after 1 and 5 d of IMQ; there is
also increased IFE cell proliferation after both treatment dura-
tions (Fig. 1B). Interestingly, we observed a trend for diurnal
rhythm in epidermal thickness in homeostasis. This diurnal var-
iation was significant after 1 d of IMQ, but lost after 5 d of IMQ
(Fig. 1C). Furthermore, spleen weight, a measurement of sys-
temic inflammation, differed significantly across the day/night
cycle under homeostasis and after 1 d of 1% IMQ but was
constitutively elevated by 5 d of IMQ (Fig. 1D).
We also performed experiments in Bmal1 knockout (KO)
mice, and found that, while their spleens weigh less under ho-
meostasis and after 24 h of nighttime IMQ treatment compared
to Wt (SI Appendix, Fig. S1A), they did not differ significantly by
5 d of IMQ (SI Appendix, Fig. S1B). On the other hand, epidermal
thickness was increased in Bmal1 KO mice compared to Wt after
5 d of IMQ (SI Appendix, Fig. S1C). Although Bmal1 KOs had
greater epidermal proliferation under homeostasis as previously
observed (4), the proportion of proliferating cells in the epi-
dermis of Bmal1 KO and Wt mice did not differ significantly
after 5 d of repeated IMQ treatment at the timepoint measured
(ZT13) (SI Appendix, Fig. S1 D and E). We also treated ears with
IMQ, measured ear width, and found a trend for increased ear
width in Bmal1 KO mice compared to Wt at days 4 and 5 but not
at 6 d of IMQ treatment (SI Appendix, Fig. S1F).
These data demonstrate that: 1) systemic and skin-specific in-
flammation progressively increased from short-term (1 d) to re-
peated (5 d) treatment with IMQ; 2) increased inflammation
associated with repetitive doses of IMQ obliterates diurnal
rhythms in IFE stem cell proliferation and thickness and in spleen
weight; and 3) in the absence of Bmal1, IMQ-induced epidermal
hyperplasia is exacerbated.
To test whether the IMQ-induced obliteration of diurnal rhythms
in IFE stem cell proliferation and inflammatory parameters was
associated with altered clock gene expression, we measured the
expression of clock output genes in mouse back skin after 6 h,
24 h, and/or 5 d of 1% IMQ treatment. Rhythmic expression of core
clock genes Bmal1 and Dbp measured by qPCR (SI Appendix, Fig.
S1 G and H) and microarray (SI Appendix, Fig. S1I) (25) after 1
and 5 d of IMQmatches control when it is measured 24 h after the
last dose of IMQ. However, if we look at a more immediate
timepoint (6 h) after a single IMQ treatment, IMQ dampens
rhythmic Bmal1 expression (SI Appendix, Fig. S1J) and down-
regulates both Rev-erbα and Dbp to similar levels as seen in Bmal1
KO (SI Appendix, Fig. S1 K and L). These qPCR results are con-
firmed by our microarray studies (25), which also show abnormal
up-regulation in Cry1/2 and Per2 (SI Appendix, Fig. S1M).
To explore the mechanism by which the circadian clock mod-
ulates IMQ-induced inflammation, we assessed the expression of
Il23r, since a previous study (10) showed that IL-23R expression
in γ/δ+ T cells from the spleen or lymph node was altered by
Clock mutations and correlated with IMQ-induced inflamma-
tion. Interestingly, we found no diurnal rhythm of Il23r expres-
sion in the skin at the timepoints assessed, and no difference
between Bmal1 KO and Wt (SI Appendix, Fig. S1N).
Consistent with IMQ-induced inflammation altering clock
gene expression in murine skin (SI Appendix, Fig. S1 J–M), we
found that the expression of core clock genes (ARNTL, CRY2,
PER1, PER2, DBP, and NR1D1) is altered in human psoriatic
lesions compared to uninvolved skin from the same patient
collected at the same time (Fig. 1E and SI Appendix, Fig. S1 O
and Q). Diurnal cell cycle genes (WEE1, CCNB1, UBE2C,
MK167, BIRC5, and CDK1) also showed altered expression in
human psoriatic lesions (Fig. 1F and SI Appendix, Fig. S1 P and
R). WEE1, a gene which acts to inhibit cell entry into mitosis, was
down-regulated in the psoriatic lesions, whereas other cell cycle
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genes were up-regulated. This is consistent with the increase in
proliferation that we found in mice treated for 5 d with 1% IMQ.
We did not observe significant differences in gene expression be-
tween male and female patients (SI Appendix, Fig. S1 Q and R).
Together, these findings suggest that cutaneous inflammation
disrupts the skin circadian clock and alters the expression of
diurnal cell cycle genes.
IMQ Alters Gene Expression in Skin. To identify inflammatory
pathways induced by IMQ that might be subject to clock regu-
lation, we first assessed IMQ-induced gene expression changes in
skin by measuring global gene expression before (0 h) and 1, 2, 4,
6, and 24 h after a single application of IMQ at ZT09. K-means
clustering followed by gene ontology (GO) analysis was used to
identify gene pathways induced or repressed by IMQ. We found
that 5,762 genes were significantly altered across the 24-h time
course. These genes could be grouped into 10 temporal clusters,
each with enrichment of specific functional categories, including
cluster 2 that was markedly up-regulated by 4 h and enriched for
IFN-β–associated genes (Fig. 2A).
We also compared genes that were up-regulated and down-
regulated after 1 and 5 d of IMQ (Fig. 2B and SI Appendix, Fig.
S2). To do this, we treated mice with IMQ at ZT01, ZT07, ZT13,
or ZT19 and collected back skin 24 h after single doses, or 24 h
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Fig. 1. IMQ effects on inflammation and core clock gene expression. (A) IMQ treatment protocol. Mice were treated topically with 1% IMQ (colored arrows)
at 6-h intervals throughout the day/night cycle (indicated by white and black bars) for either 1 d, or each day for 5 d, and collected 1 d after the last treatment.
(B) Epidermal cell proliferation (EdU+ cells). Two-way ANOVA test shows significance between treatments (P = 0.02) and time points (P = 0.005). Tukey’s post
hoc test for control vs. 5 d 1% IMQ, P = 0.01. One-way ANOVA for control across ZT times was P < 0.003. (C) Epidermal thickness. Two-way ANOVA shows
significance between treatments (P < 0.0001), for both control vs. 5 d IMQ, and 1 d IMQ vs. 5 d IMQ (Tukey’s post hoc test P < 0.0001 for both). Epidermal
thickness after 1 d IMQ differed across ZT time (one-way ANOVA P = 0.01). (D) Spleen weights. Spleen weight differed across ZT time and treatments (two-
way ANOVA P = 0.03 and P < 0.0001). Spleens weighed more after 1 d of 1% IMQ and 5 d of 1% IMQ compared to controls (Tukey’s post hoc test, P = 0.004
and P < 0.0001). Spleen weight changed across ZT time in controls, and after 1 d of 1% IMQ (one-way ANOVA P = 0.0002 and P = 0.003, respectively). (B–D)
Control (blue, n = 5), 1 d of 1% IMQ (orange, n = 7), and 5 d of 1% IMQ (red, n = 5 to 7). Data are presented as mean ± SEM. Comparison of gene expression of
core clock genes (E) and cell cycle genes (F) between uninvolved and psoriatic biopsies using RNA-seq data from human skin biopsies. Uninvolved and
psoriatic biopsies were collected from the same patient (n = 27) during the time between 9 AM and 4 PM (E and F). (Data in E and F from ref. 47.) Statistical
significance was determined by Student’s paired t test and significant P values are shown.
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after the last dose of 5 consecutive days of treatment (as described
in Fig. 1A). Of the 7,153 genes that were up-regulated after 1 or 5
d of IMQ, 327 were up-regulated in both treatments, leaving 130
uniquely up-regulated after 1 d of IMQ and 6,696 uniquely up-
regulated after 5 d of IMQ (Fig. 2B). In addition, 6,889 genes
were down-regulated after 1 or 5 d of IMQ. Of the 6,889 genes, 90
were uniquely down-regulated after 1 d of IMQ, 5,781 were
uniquely down-regulated after 5 d of IMQ, and only 18 were
down-regulated after both 1 and 5 d of treatment (Fig. 2B). The
number of genes up-regulated or down-regulated was also time-
of-day specific (SI Appendix, Fig. S2).
After 1 and 5 d of IMQ, 566 and 12,871 genes, respectively,
were significantly altered compared to control (Fig. 2C). To explore
what the physiological significance of these gene expression
changes may be, we performed gene set enrichment analysis
(GSEA) to identify gene ontologies that were enriched based on
our differential gene expression analysis (Fig. 2D). After a single
treatment with IMQ, enriched hallmark pathways associated
with the immune system included allograft rejection, IL-6 Jak/
Stat3 signaling, inflammatory response (including IFN-α/IFN-γ
response), KRAS signaling down-regulated, and IL-2/Stat5 sig-
naling (Fig. 2 C and D). These data also point to IFN signaling
being prominent after a single dose of IMQ. Pathways enriched
after five daily applications of IMQ included protein secretion,
G2M checkpoint, and metabolic-associated pathways (Fig. 2 C
and D). These findings are supported by the earlier results
that IFE cell proliferation is markedly increased after 5 d of
treatment.
Fig. 2. Summary of differentially expressed genes (DEGs) and ISGs following single and multiple treatments of 1% IMQ. (A) Heatmap of expression of differ-
entially expressed genes across time, normalized across genes. (B) Venn diagrams of up-regulated and down-regulated genes between 5 d 1% IMQ vs. control and
1 d 1% IMQ vs. control. Scale of circle to other circles within the same diagram do not correspond with number of genes in category. DEGs were identified using
Tukey’s post hoc test with a P < 0.05. (C) Heatmap of expression of DEGs between control, 1 d 1% IMQ, and 5 d 1% IMQ timepoints normalized across genes. (A
and C) K-means clustering was performed, and clusters were color coded. Color-coded tables on Right list relevant gene ontologies for cluster associatedwith color.
Tables also list the number of genes in each cluster and the number of genes in GO category, number of genes in GO category in the cluster, fold enrichment of GO
category in the cluster, and false discovery rate (FDR) value. DEGs were identified using one-way ANOVA and Tukey’s post hoc test. For the heatmap, green, low
expression and red, high expression. (D) Two-dimensional (2D) heatmap of GO categories determined using GSEA for 1 or 5 doses of 1% IMQ. Size of circle
corresponds to significance of GO category for the treatment and condition. Color of the circle corresponds to enrichment of category.
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Overall, these data point to the IFN pathway as a mediator of
the early response to a single dose of IMQ (14). In addition, while
some diurnal gene expression changes persist over 5 d of IMQ
treatment, a much larger set of genes becomes dysregulated with
repeated treatment over multiple days.
Diurnal Gene Expression Responses to IMQ Skin Treatment. To
identify genes and gene ontology categories that respond to IMQ
in a time-of-day–dependent manner, we averaged the gene
expression for daytime timepoints (ZT01 and ZT07) and night-
time timepoints (ZT13 and ZT19). We then used a fold cutoff of
1.2 or greater to define genes differentially expressed between day
and night. Out of the 566 genes significantly altered after 1 d of
IMQ, 17 genes showed greater up-regulation when IMQ was ap-
plied during the day compared to the night and 78 genes showed
greater up-regulation when IMQ was applied during the night
compared to the day. The genes with greater induction after
daytime IMQ were enriched for IFN-α response, IFN-γ response,
adipogenesis, fatty acid metabolism, and myogenesis (Fig. 3A).
The genes with greater up-regulation when IMQ was applied
during the night did not form specific functional categories. After
five daily IMQ treatments at night, enriched pathways were as-
sociated with cell cycle regulation, E2F and Myc targets, TNFα
signaling via NF-κB, and IL-2/STAT5 signaling. However, there
were few enriched pathways after 5 d of daytime IMQ treatment,
and these pathways were associated mainly with metabolic func-
tions (Fig. 3A). These findings suggest distinct time-of-day–
dependent gene expression changes after single and repeated
IMQ doses, with greater IFN responses after one dose of IMQ
during the day, and greater cell cycle pathway enrichment after
nighttime treatment for 5 d with IMQ.
As many of IMQ’s immunogenic effects are mediated through
induction of IFN pathways (27), we further investigated genes
associated with the IFN response. By GSEA, the IFN-α and IFN-γ
response genes were markedly enriched among genes that were
expressed higher after a single dose of IMQ during the day than
night (Fig. 3B). Using theMolecular Signatures database (MSigDB),
we identified 202 ISGs, some of which were up-regulated after
1 d of IMQ, and others were up-regulated by 5 d of IMQ (Fig. 3C).
We further analyzed the 202 ISGs by identifying which were up-
regulated, on average, by 1.2-fold or greater after 1 d of IMQ (53
genes); there is a clear diurnal difference with greater expression
of these up-regulated genes during the day compared to the
night after 1 d of IMQ (Fig. 3D). The expression pattern of Irf7,
a master regulator of ISG transcription, when measured by
qPCR, had greater induction after IMQ treatment during the
day than night after 1 d (Fig. 3E), consistent with the results of
the microarray study (25).
To more specifically define the biological processes that the 53
up-regulated ISGs could be regulating, we performed gene on-
tology analysis using the online database DAVID (28). The ma-
jority of these genes were associated with antiviral activities;
examples include genes encoding antiviral proteins that inhibit
replication of RNA viruses, such as Isg15, Ifit1,Mx1, andOas1a, as
well as negative feedback factors that dampen proinflammatory
responses, such as Irgm1, Usp18, and Trim30.
In sum, IMQ treatment alters skin gene expression which
differs depending on both the treatment time during the circadian
cycle and length of treatment (1 d or 5 d). There is a time-of-day–
dependent induction of ISG-associated pathways (IFN-α and IFN-γ
response) 1 d after a single dose of IMQ, whereas few pathways,
mainly associated with cell cycle or metabolism, exhibit diurnal
regulation after 5 d of daily IMQ treatment (Fig. 3A).
IMQ Up-Regulates ISG Expression in Epidermal Cell Subsets. To de-
fine which epidermal cell types induce ISG expression in re-
sponse to IMQ, we performed single-cell RNA-seq on epidermis
isolated from adult mice under homeostasis and 6 h after a single
dose of IMQ (26). We used Seurat (29) to cluster cells based on
their gene expression profiles and t-distributed stochastic
neighbor embedding (t-SNE) to display the cell clusters, which
were annotated manually based on markers from previous
studies (30). To assess any compositional differences between
the control and treated samples, we pooled the control and
IMQ-treated samples onto one t-SNE plot (Fig. 4A). By ana-
lyzing each of the 13 clusters (we also had a small cluster of
contaminating fibroblasts), we determined the relative change in
the percent of cell types in IMQ-treated samples over the control
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Fig. 3. Analysis of genes and ISGs following day or night 1% IMQ treatment. (A) Two-dimensional (2D) heatmap of GO categories determined using GSEA in
two different treatment groups (night vs. day and day vs. night) across three conditions (control, 1 d 1% IMQ, and 5 d 1% IMQ). Size of circle corresponds to
significance of GO category for the treatment and condition. Color of the circle corresponds to enrichment of category. (B) Enrichment plot for IFN-α and IFN-γ
hallmark pathways shows a significant enrichment of these pathways after 1 d of 1% IMQ during the day vs. night. (C) Heatmap of 202 ISGs (from MSigDB)
from the samples collected in Fig. 2C. Green, low expression and red, high expression. (D) Average normalized whole skin microarray expression (25) of ISGs
induced by 1.2-fold or more after IMQ, under homeostasis (blue), 1 d 1% IMQ (orange), and 5 d 1% IMQ (red). One-way ANOVA, control P = 0.001, 1 d 1%
IMQ P < 0.0001, 5 d 1% IMQ P = 0.56. (E) qPCR for Irf7 on individual samples collected in Fig. 1A. Student’s unpaired t test comparing daytime vs. nighttime
under control [not significant (N.S.)], 1 d (P = 0.02), and 5 d (N.S.). Data represents mean ± SEM of n = 5 to 7.
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Fig. 4. IMQ up-regulates ISG expression in keratinocytes, Langerhans cells, T cells, and monocytes within the epidermis. scRNA-seq was performed on
epidermal cells isolated from control and 6 h of 1% IMQ-treated mice (26). (A) Cell from both control (pink) and 6 h 1% IMQ (blue) samples were jointly
projected on the same t-SNE plot to better compare different cell subtypes. (B) Histogram representing the relative changes of each cell type in control and
IMQ samples. Positive value bars represent percent of cells that were more present in IMQ-treated samples over control and negative value bars the opposite.
(C) t-SNE plots of cells isolated from adult male mice, untreated (Left) or treated with 1% IMQ for 6 h (Right). Differentiated keratinocytes (KC D), basal
keratinocytes (KC B), basal infundibulum (Infu B), mitotic keratinocytes (KC M), Langerhans cells (LCs), sebaceous gland (SG), melanocytes (MCs), fibroblasts
(fibro), monocytes (mono), T cells (TC), Isthmus cells, outer bulge cells group 1 (OB-I), outer bulge cells group 2 (OB-II), and inner root sheath cells (IRS). N refers
to the number of cells per population. (D) Irf7 mRNA expression in single-cell data (26). Gray, no expression; red, intensity of expression. (E) Proportion of
differentiated KCs (KC D; Krt1+), basal KCs (KC B; Col17a1+), T cells (TC; Cd3g+), LCs (Cd207+), and monocytes (mono; Cybb+) expressing Irf7 in control and
IMQ-treated samples. Normalized Irf7 expression is on the x axis and the proportion of cells expressing Irf7 mRNA out of each population is on the y axis.
Number of cells analyzed and percent of each population out of total cells analyzed is listed above each graph. Number and percent of cells expressing Irf7
out of each population is listed in red. χ2 test results (Right) of the portion of positive Irf7 between control and treated samples of selected subpopulations
and the corresponding P values.
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(Fig. 4B). We noticed a small cluster of immune cells in normal
epidermis, which we classified as monocytes (labeled “mono”) by
searching the top 50 genes that were differentially expressed in
this cluster compared to other epidermal populations in the
Immunological Genome Project (Immgen) database (31) (SI
Appendix, Fig. S3A). Genes enriched in the monocyte population
include myeloid-associated genes (Ly6e, CD14, and Lyz2), M2 po-
larization markers (CD16 and Adgre1 [F4/80]), phagolysosomes/
oxidative burst (Coro1a, Ctss, Cyba, Cybb, and fcgr3), and che-
mokines (Ccl6, Ccl4, Ccl3, and Ccl9). Interestingly, the percent of
monocytes increased by greater than 100% following treatment
with IMQ compared to control, indicating that IMQ plays a
role in the recruitment of monocytes. On the other hand, some
cell populations were absent in the IMQ sample: fibroblasts,
melanocytes, outer bulge group 2 cells, and inner root sheath cells.
We also studied the control and IMQ-treated samples sepa-
rately (Fig. 4C), identifying 14 clusters for control and 10 clusters
for IMQ treated. Under homeostasis, we detected few Irf7 pos-
itive cells within the epidermis (Fig. 4D), with highest expression
found in the monocyte population. After IMQ, we identified
four main cell populations that increased expression of Irf7: a
small group of KCs, LCs, T cells, and monocytes (Fig. 4D). Irf7
expression was consistent with the expression of the 53 ISGs
identified in Fig. 3D (SI Appendix, Fig. S3A).
Out of all cell types, the small group of monocytes expressed
Irf7 and ISGs most robustly in response to IMQ (Fig. 4E and SI
Appendix, Fig. S3B). Fifty percent of monocytes expressed Irf7
under homeostasis, while 88% expressed Irf7 after IMQ (Fig. 4E).
Out of the differentiated KC (Krt1+) population, 4% of cells express
Irf7 under homeostasis, and this increases to 8% after IMQ. The
same trend was observed in the basal KC population (Col17a1+)
(Fig. 4E). In T cells (Cd3g+) and LCs (Cd207+), 8% and 1% of cells
expressed Irf7 under homeostasis, and this increased to 42% and
26%, respectively, after IMQ (Fig. 4E). Interestingly, only the
monocytes from the control sample expressed Tlr7 (Tlr7 was
not detected in the IMQ sample) (SI Appendix, Fig. S3C).
We found that, at the single-cell level, core clock genes Rev-
erbα (Nr1d1) and Dbp were suppressed by 6 h of IMQ (SI Ap-
pendix, Fig. S3D) in the major cell populations of keratinocytes
(Isthmus, KC B, and KC D) (26). In addition, we fluorescence-
activated cell sorting (FACS) sorted epidermal cell subsets
(T cells, DCs, and CD49f+ KCs) after 6 h of IMQ during the day
(ZT0) or night (ZT12) and performed qPCR for Dbp and found
similar down-regulation (SI Appendix, Fig. S3E). These results
support the data presented in SI Appendix, Fig. S1 D–G showing
6 h of IMQ down-regulates the expression of certain core
clock genes.
Taken together, these results show that multiple cell types
within the epidermis respond to IMQ by up-regulating Irf7 and
ISG expression and down-regulating Rev-erbα (Nr1d1) and Dbp
expression. In terms of ISG expression, immune cells, mainly
monocytes and T cells, are the most potent responders, followed
by LCs and a small population of KCs.
IMQ Induces Total and Phosphorylated-IRF7 Protein Nuclear
Translocation in Epidermal Cell Subsets. To activate ISG expres-
sion, IRF7 must be phosphorylated and translocated into the
nucleus (13). To test whether IRF7 nuclear translocation dif-
fered depending on the time of day of IMQ application, we
treated mice topically with IMQ during the day (ZT07) or night
(ZT19) and collected epidermal cells 6 h and 1 d later and an-
alyzed IRF7 and phosphorylated IRF7 (p-IRF7) nuclear locali-
zation with the ImageStream Flow Cytometer (Fig. 5A) (32).
We measured nuclear similarity index (a measurement of the
relative nuclear localization of a given marker) of total IRF7 and
p-IRF7, finding that monocytes (CD11c−CD3e−CD45+) had
greater nuclear localization of total and p-IRF7 after 6 h of IMQ
during the day than night. At 1 d, p-IRF7 nuclear localization was
significantly increased and similar at both treatment times (Fig.
5B). Similar results were seen for T cells (Fig. 5C). Nuclear lo-
calization of total IRF7 and p-IRF7 was significantly increased in
KCs 1 d after IMQ compared to control, with greater nuclear
localization of total IRF7 seen after nighttime IMQ treatment
compared to daytime treatment (SI Appendix, Fig. S4A). In DCs,
no significant increase in nuclear localization of total or p-IRF7
6 h after IMQ was observed, but by 1 d, nuclear localization of
total and p-IRF7 was significantly increased with no time-of-day
dependence (SI Appendix, Fig. S4B).
In summary, the activity of IRF7, indicated by its phosphory-
lation and nuclear localization, is induced after IMQ in epider-
mal KCs, T cells, dendritic cells, and monocytes, but is time-of-
day dependent only in T cells and monocytes.
Systemic Deletion of Bmal1 Increases IMQ-Induced ISG Expression in
the Skin. We tested how IMQ treatment length affected the di-
urnal ISG response and whether the circadian clock plays a di-
rect role in the rhythmic IMQ-induced ISG response. We treated
Wt and Bmal1 KO mice topically with IMQ and collected dorsal
skin 6 h or 1 d after IMQ treatment during the day (ZT07) or
night (ZT19). Wt mice had greater induction of Irf7 after 6 h of
IMQ during the night than the day (Fig. 6A), which contrasts
with that observed with 1 d after treatment in which Irf7 is more
highly induced after daytime than nighttime IMQ treatment
(Figs. 3E and 6A). These findings suggest that the diurnal ISG
response elicited by IMQ is dependent on treatment duration;
the shorter treatment duration (6 h) leads to greater response at
night, whereas the longer treatment duration (1 d), the time at
which Irf7 expression peaks after IMQ, leads to greater response
during the day (Fig. 6A).
We then tested the IMQ effect in mice deleted for Bmal1. Irf7
gene expression was increased in the skin of Bmal1 KO mice
compared to Wt after 6 h of IMQ treatment during the day,
whereas there was no difference between the genotypes after 6 h
of IMQ at night; the 1 d of IMQ treatment of Bmal1 KO mice
induced significantly greater Irf7 expression compared to Wt,
irrespective of whether IMQ was applied during the day or night
(Fig. 6A). These findings are consistent with the circadian clock
controlling the diurnal response to IMQ. Also, in contrast to
epidermis isolated from Wt mice, Irf7 mRNA was induced by
approximately fourfold 1 d after IMQ, with no diurnal difference
(Fig. 6B). Interestingly, Irf7 mRNA in the epidermis of Bmal1
KO mice was exacerbated almost fourfold after IMQ compared
to Wt (Fig. 6B).
To determine whether systemic type I IFN activity was af-
fected by Bmal1 deletion, we measured serum IFN-β levels in Wt
and Bmal1 KO mice treated topically with IMQ for 2 or 6 h
during the day or night. There was no significant IFN-β induction
after 2 h of IMQ in either genotype, whereas IFN-β levels were
significantly more up-regulated after 6 h of IMQ in the Bmal1
KO mice compared to control, both when IMQ was applied
during the day or the night (Fig. 6C). After 1 d of IMQ, IFN-β
levels were similar to control in the Wt, while Bmal1 KO mice
maintained elevated IFN-β levels (Fig. 6D).
To decipher whether the diurnal and BMAL1-affected ISG
response to IMQ was a result of differential recruitment of im-
mune cells (which express ISGs more robustly compared to KCs)
(Fig. 4), we measured the immune cell composition in the epi-
dermis (Fig. 6E). We observed no major significant difference in
composition of immune cells, including T cells, DCs, monocytes,
and after 6 h of IMQ during the day vs. night in Wt and Bmal1
KO mice (Fig. 6E).
These results show that the antiviral (ISG) response to IMQ
not only depends on the duration of treatment and the time of
day, but is also greatly impacted by deletion of Bmal1. Further-
more, this effect is mediated at the transcript level, as the cellular
composition of immune cells within the skin is unaffected by time
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of day or Bmal1 deletion. Based on these data, we hypothesize
that Bmal1 plays a regulatory role in suppressing type I IFN levels
and ISG expression.
Feeding Schedules Alter the Skin’s Type I IFN Response after IMQ.
Previously we found that the rhythmic skin expression of many
immune-associated genes was shifted after daytime-restricted feeding
(3). Some of these genes encode for proteins that mediate the
IMQ-induced ISG response, including Tlr7, Ifnar2, and Irf7.
Therefore, we sought to determine if shifting the skin clock with
time-restricted feeding could affect the rhythm of the IMQ-
induced ISG response. We subjected mice to time-restricted feed-
ing with EN (early night; ZT12–ZT16) and MD (midday; ZT05–
ZT09) feeding schedules as well as an AD (ad libitum) feeding
A
B C
Fig. 5. IMQ-induced nuclear localization of total and phosphorylated IRF7 is diurnal in epidermal T cells and monocytes. Male Wt mice were treated with 1%
IMQ for 6 h or 1 d during the day (ZT07) or night (ZT19) and back epidermis was dissociated, stained for cell surface markers and intracellular IRF7 and p-IRF7,
and analyzed on the ImageStream Flow Cytometer. Nuclear localization index was calculated using IDEAS software. (A) Example images (60x) taken during
ImageStream fluorescence imaging, showing a cell with no p-IRF7 nuclear localization (Top) and one with p-IRF7 nuclear localization (Bottom). (B) Average
nuclear translocation index for total IRF7 (Left) and p-IRF7 (Right) in monocytes (CD45+CD11c−CD3e−). (C) Average nuclear translocation index for total IRF7
(Left) and p-IRF7 (Right) in T cells (CD45+CD3e+CD11c−). (A–C) Each data point represents one mouse, and mean ± SEM is indicated. Statistical significance was
determined by Student’s paired t test and significant or near-significant P values are shown.
A B C D
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Fig. 6. Systemic Bmal1 deletion results in exacerbated IMQ-induced serum IFN-β and ISG expression in the skin. (A) Irf7 qPCR on whole back skin from Wt
(blue, n = 17 to 30) and Bmal1 KO mice (red, n = 6 to 9) after 6 h or 1 d of 1% IMQ during the day (ZT07) or night (ZT19). (B) Irf7 qPCR on isolated epidermis
from Wt (blue, n = 10 to 18) and Bmal1 KO mice (red, n = 4 to 8) after 1% IMQ during the day (ZT07) or night (ZT19) for 1 d. (C) Wt serum IFN-β after 2 or 6 h
of 1% IMQ during the day (ZT07) or night (ZT19). (D) Wt (blue) vs. Bmal1 KO (red) serum IFN-β after 1 d of 1% IMQ at ZT07. (E) Flow cytometry quantification
of immune cell populations within the epidermis in Wt and Bmal1 KO mice treated with 1% IMQ for 6 h during the day or night (indicated by white and black
bars). (A–E) Each data point represents one mouse, and mean ± SEM is indicated. The numbers above each group indicate the number of samples analyzed.
Statistical significance was determined by Student’s paired t test and significant or near-significant P values are shown.
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schedule as a control (Fig. 7A). After 21 d, these mice were
treated topically with IMQ during the day (ZT07) or night
(ZT19), and skin was harvested for RNA analysis 1 d later (Fig.
7A). Consistent with our previous findings (Fig. 3D), AD mice
exhibited a diurnal rhythm of ISG induction after IMQ, as shown
by the expression of the 53 induced ISGs identified in Fig. 3D
(Fig. 7 B and C). Interestingly, in MD mice this rhythm was
reversed with greater ISG induction after IMQ treatment during
the night than during the day (Fig. 7 B and C). qPCR for Irf7
expression in individual mice (Fig. 7D) confirmed the results
from the microarray study (Fig. 7C) (25). To assess whether re-
stricted feeding impacts the systemic inflammatory response to
IMQ, we measured spleen weight in these mice and found that in
AD mice, spleen weight is higher during the day than at night
under homeostasis, and that a similar trend is observed after 1 d
of 1% IMQ. The EN and MD feeding groups generally exhibited
decreased spleen weight compared to AD and no diurnal differ-
ences (Fig. 7E). These results demonstrate that time-restricted
feeding, which shifts the phase of the skin circadian clock (3),
shifts the rhythmic expression of ISGs after IMQ, suggesting
that meal timing may directly affect our susceptibility to insults
protected against by the ISG response.
Discussion
Our study sheds light on the underappreciated role of the cir-
cadian clock in regulating IFN responses in skin, a response im-
portant for defenses against skin cancer and viral infections and a
pathogenetic mechanism in chronic autoimmune diseases such as
psoriasis. The study also suggests that the response to IMQ—a
drug used to treat actinic keratosis, superficial basal cell carci-
noma, and other dermatological diseases—may be time-of-day
dependent. Furthermore, we demonstrate that the IFN response
to IMQ is modulated by time of feeding, suggesting that feeding
has a previously unrecognized influence over the skin immune
response.
An important barrier against infections and injury, the epi-
dermis constantly renews through the proliferation of IFE stem
cells (1). In these stem cells, the circadian clock controls diurnal
rhythms in DNA replication and repair (4, 33–35); deletion of
Bmal1 leads to higher and constant IFE cell proliferation (4).
We propose that these daily cell proliferation rhythms allow
coordination with diurnal cycles in oxidative phosphorylation and
glycolysis to minimize ROS-induced genotoxicity (1, 4, 5). Here we
find that IMQ-induced inflammation overrides the circadian
control of the cell cycle, causing increased and constant IFE stem
cell proliferation (Fig. 1B), similar to that found in the absence of
Bmal1 (SI Appendix, Fig. S1D). This is especially pronounced after
repeated IMQ doses. We speculate that it is advantageous to
suspend the clock control of the cell cycle in stem cells to maxi-
mize the proliferative response to inflammation-induced tissue
injury. Consistent with this idea, we found that topical IMQ ap-
plication acutely down-regulates clock output genes Bmal1, Dbp,
and Rev-erbα 6 h after treatment and up-regulates negative
BMAL1:CLOCK regulators, Cry1/2 and Per2 (SI Appendix, Fig. S1
J–M). While core clock gene expression was restored 24 h after
a single treatment in mice, we observed that human psoriatic skin
biopsies had constitutively dampened core clock gene expression
(Fig. 1 and SI Appendix, Fig. S1). We also found that 5-d treatment
with IMQ markedly increased and obliterated diurnal rhythms in
spleen weight (Fig. 1D), suggesting that IMQ-induced inflamma-
tion may suspend diurnal rhythms in the systemic immune
response.
A previous study found greater skin thickening when IMQ was
applied at night than during the day, suggesting diurnal rhythms
in inflammatory activity, even after repeated daily treatments with
IMQ (10). In contrast, we demonstrate that repeated IMQ admin-
istration disrupts circadian control of the epidermal proliferation and
A B C
D E
Fig. 7. Shifting the clock by daytime-restricted feeding (RF) alters the diurnal rhythm of IMQ-induced ISG expression. (A) Restricted feeding followed by IMQ
treatment protocol. Mice were subjected to RF feeding schedules and then shaved and treated with 1% IMQ during the day (ZT07) or night (ZT19) for 1 d and
then whole skin was collected for qPCR and pooled for microarray analysis (25). AD, ad libitum fed; EN, early night fed; MD, midday fed. (B) Heatmap of 202 ISGs
(fromMSigDB) from the samples collected in A. Green, lowly expressed genes; red, highly expressed genes. (C) Whole skin microarray expression of ISGs identified
by MSig database (25), up-regulated by 1.2-fold or more after 1 d of treatment, is plotted. Data points indicate individual ISG expression values after IMQ, with
average ISG expression per group indicated by colored lines (AD, orange; EN, blue; MD, red). Statistical significance was measured by one-way ANOVA and
significant P values are shown. (D) Whole skin RNA samples from A were subject to qPCR for Irf7 (n = 5 to 14). Data are presented as mean ± SEM. (E) Spleen
weights of mice 1 d post-1% IMQ treatment. (D and E) Data presented with points representing individual mice at ZT07 (white) and ZT19 (black), and colored bars
representing the mean with error bars indicating ± SEM. Statistical significance was determined by Student’s paired t test, and significant P values are shown.
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thickness (Fig. 1). Differences between the two studies may account
for these results: they used 2.5% IMQ cream, we used 1% IMQ;
they analyzed ear skin, we analyzed back skin; they used ICR al-
bino female mice, we used male C57/B6J mice. The two mouse
strains have been shown to have different inflammatory responses
to repetitive IMQ treatment (36); ICR mice have greater IMQ-
induced splenomegaly compared to C57/B6J, but C57/B6J have
greater epidermal thickness and weight loss in response to IMQ
than ICR mice (36).
In the skin, topical IMQ treatment induces the production of
ISGs which facilitate proinflammatory, antiviral immunity and
help steer the host’s innate and adaptive immune system to de-
fend against pathogens and cancers. Our results show that the
acute ISG response in the skin elicited by IMQ is time-of-day
dependent, while chronic treatment (5 d) results in ablation of
rhythmic ISG expression (Fig. 3). We observe greater ISG in-
duction after 6 h of IMQ treatment during the night compared to
the day, while by 1 d after treatment, ISGs are higher during
the day compared to the night. This temporally dynamic rhythm
in ISG expression is supported by a previous study in which
systemic injection of IFN produced greater IFN-induced mye-
losuppressive activity during the night at early (12 h) timepoints,
whereas by 24 to 48 h myelosuppressive activity was greater
during the day (37). Moreover, IFN administration during the
day yielded higher antitumor activity than IFN administered at
night, highlighting the functional significance of circadian IFN
responsiveness (38).
This study identifies a population of IRF7-expressing monocytes
within the mouse epidermis under homeostasis. In response to
IMQ, this population turns on ISG expression most robustly out of
all cell types (Fig. 4); it is tempting to posit that these cells are key
initiators of IFN-mediated defense responses in the skin. Consistent
with that notion, under homeostasis this is the only cell population
that expresses Tlr7 to detectable levels in the scRNA-seq experi-
ments (SI Appendix, Fig. S3C). In epidermal T cells and monocytes,
p-IRF7 exhibits greater nuclear localization after 6 h of IMQ during
the day than night (Fig. 5), supporting the idea that IRF7 regulates
the activation of ISG expression after phosphorylation and trans-
location into the nucleus in a time-of-day–dependent manner.
We found that systemic Bmal1 KO mice have an exacerbated
IMQ-induced ISG response in skin and isolated epidermis. Con-
sidering that the Bmal1 KO phenotype is observed in isolated
epidermis (Fig. 6), and mainly epidermal immune cells (few KCs)
up-regulate Irf7/ISG expression after IMQ (Fig. 4), we propose
that BMAL1 acts as a negative transcriptional regulator of ISGs in
a cell-type–specific manner, mainly in skin-residing or infiltrating
leukocytes. This hypothesis does not exclude the possibility that
BMAL1 also regulates the ISG response in other cells; consider-
ing that we observe elevated serum IFN-β levels after IMQ in
Bmal1 KO mice, it is likely that BMAL1 plays this regulatory role
in other immune populations throughout the body.
BMAL1 has been described as a positive regulator of antiviral
responses. Intranasal influenza A, herpesvirus, and Sendai virus
infections in mice exhibit greater virulence during the day than
night, with deletion of core clock genes causing increased viral
titers and mortality (11, 12). Furthermore, BMAL1 inhibits rep-
lication of respiratory syncytial virus and parainfluenza virus type
3 viruses in a cell-intrinsic manner (39). Here, we demonstrate
that Bmal1 deletion increases the expression of ISGs in response
to a TLR7 agonist. The increased susceptibility to viral infections
in Bmal1 KO mice despite a more robust ISG response (also
shown by others) (12) can be reconciled by multiple explana-
tions. First, excessive IFN responses worsens pathologies by re-
ducing the effectiveness of the adaptive immune system, such as
in chronic IFN signaling due to a lymphocytic choriomeningitis
virus infection (40), indicating that the antiviral power of the
IFN-activated pathways requires a balance between activating
signals and inhibitory mechanisms. Additionally, recombinant
IFN-β treatment in patients with relapsing-remitting multiple
sclerosis suppress T cell activity, leading to better prognoses (41).
Second, Bmal1 deletion results in up-regulation of the core clock
gene CLOCK (4, 42), which associates with the viral transcrip-
tional complex of the herpesvirus to mediate viral gene expres-
sion (43, 44). Third, cells lacking circadian clocks have elevated
expression of certain protein biosynthesis enzymes, some of which
are controlled by the circadian clock, and may facilitate greater
production of viral gene products in cells whose transcriptional
machinery has been hijacked by viral effectors (11).
Timing of food intake alters the circadian clock in peripheral
organs (3, 45). We previously showed that shifting the skin clock
via time-restricted feeding affects the amount of UVB-induced
DNA damage (3). In relation to our study, time-restricted feeding
affects adrenal gland glucocorticoid secretion, which in turn reg-
ulates IFN-α/β receptor 1 expression in the liver (46). We expand
on these results and demonstrate that the rhythmic expression of
many ISGs was shifted after IMQ treatment, suggesting that sus-
ceptibility to viral infections and tumorigenesis may be affected by
meal timing (Fig. 7).
In conclusion, we show: 1) Core clock gene expression is altered
by cutaneous inflammation; 2) a requirement for core clock gene
Bmal1 for diurnal rhythms in the skin’s ISG response, suggesting
the circadian clock modulates the ISG response in skin; 3) that a
population of epidermal leukocytes, rather than the bulk pop-
ulation of keratinocytes, mediates the most robust IFN response
to IMQ; and 4) that shifting the clock by daytime-restricted
feeding reverses the phase in ISG pathway activation in the skin,
suggesting that meal timing may be a previously unknown mod-
ulator of skin immune responses.
Materials and Methods
Detailed descriptions of all materials and methods are available in SI
Appendix.
Animals.Mice were maintained according to NIH guidelines and approved by
the Institutional Animal Care and Use Committee of the University of Cal-
ifornia, Irvine (protocol number 2001-2239).
IMQ Treatment. All mice (including controls) were anesthetized by i.p. injection
with ketamine (100 mg/kg) and xylazine (10 mg/kg) and shaved 2 d prior to
experiment initiation. Tomake1%IMQcream, 5%pharmaceutical IMQ (Perrigo
brand) was diluted in a ratio of 1:4 with CVS moisturizing cream. The 1% of the
stock 5% cream was weighed out in 0.0625 g aliquots to apply to the back and
0.031 g aliquots to apply to the ears. For some experiments, mice were injected
with EdU at 5 mg/kg of body weight 2 h prior to collection. For specimen
collection, micewere killed by CO2 followed by cervical dislocation.Whole back
skins were collected and preserved in RNAlater (Thermo Fisher Scientific).
Microarray Analysis of Whole Skin RNA. Whole skin RNA from four to seven
mice with RNA integrity numbers (RINs) above 7 were pooled. A total of
200 ng of total RNA was hybridized to Affymetrix Mouse Gene 1.0 ST arrays.
All reads were Plier normalized, and duplicate reads and genes with expression
level below 50 were removed. Expression was Log2 transformed and mean
centered across all arrays being compared.
Analysis of RNA-Seq Data of Human Skin Biopsies. Uninvolved and psoriatic
biopsies were collected from the same patient at the same time (between
9 AM and 4 PM). The Log2-transformed data were used for downstream analysis.
Human data were acquired from a published dataset (47). All subjects involved
in this study provided written informed consent under a protocol adherent to
the Helsinki Guidelines and approved by the Institutional Review Board of the
University of Michigan Medical School.
Single-Cell RNA-Seq Analysis: Data Processing and Dimension Reduction and
Clustering Analysis. For downstream analyses, low-quality cells were removed
based on the outliers of a distribution of several quality control metrics. Cells
with a number of expressed genes greater than 5,000 (control samples) or
greater than 4,500 (IMQ samples), or the proportion of counts in mito-
chondrial genes greater than 10%, were removed. In sum, 132 and 78 cells
were removed in control and IMQ samples, respectively, leading to 3,616 and
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1,673 cells for downstream analyses. Clustering of cells was performed using
the Seurat R package (29). The control and IMQ samples were analyzed
separately as well as in a pooled fashion in order to perform integrative
analysis using canonical correlation analysis (CCA) (48), as described in SI
Appendix, Materials and Methods.
Preparation of Epidermal Cells for ImageStream Analysis. Cells were stained as
described in SI Appendix, Materials and Methods. Immediately prior to ac-
quisition on the ImageStream Flow Cytometer (Amnis Corporation), cells were
incubated with 4′,6-diamidino-2-phenylindole (DAPI) to label nuclei. IDEAS
analysis software was used to calculate the nuclear translocation index of
total IRF7 and p-IRF7.
Statistical Methods. Statistics are described in the figure legends.
Data Availability. The scRNA-seq, mouse skin microarray, and human psoriasis
data discussed herein were deposited in GEO (accession nos. GSE142345,
GSE142165, and GSE63980 respectively).
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